Recent Drug Discovery Research for November 2024
Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021 Topics: Diabetes, Drug Discovery
| Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorder) - Drugs in Development, 2021 Topics: Drug Discovery
| Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 Topics: Drug Discovery
| Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 Topics: Drug Discovery, CNS/Neurology
| Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Presbyopia (Ophthalmology) - Drugs in Development, 2021 Topics: Drug Discovery, Ophthalmology
| Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021 Topics: Drug Discovery, Women's Health, Obstetrics/Gynecology, Reproductive Health
| Ovarian Cancer (Oncology) - Drugs in Development, 2021 Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology, Renal
| Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021 Topics: Drug Development, Drug Discovery
| Glaucoma - Epidemiology Forecast to 2030 Topics: Drug Discovery, Ophthalmology
| Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2030 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Regions: Global
| Endometriosis - Global Drug Forecast and Market Analysis to 2030 Topics: Drug Discovery, Women's Health, Obstetrics/Gynecology
Regions: Global
| Chronic Myeloid Leukemia (CML) - Epidemiology Forecast to 2030 Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Duchenne Muscular Dystrophy - Opportunity Assessment and Forecast to 2030 Topics: Drug Discovery
| Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery, CNS/Neurology
| Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery, CNS/Neurology
| Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Venous Leg Ulcers (Crural ulcer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery, Respiratory/Pulmonary
Regions: Global
| Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery, CNS/Neurology
Regions: Global
| Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
Regions: Global
| Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Development, Drug Discovery
| Pancreatic Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) Topics: Cancer Treatment, COVID-19/Coronavirus, Drug Discovery, Oncology/Hematology
Regions: Global
| Microscopic Polyangiitis (MPA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Ischemia Reperfusion Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Autism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Post-Operative Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Pain, Drug Discovery
| Obsessive-Compulsive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Post-Traumatic Stress Disorder (PTSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Traumatic Brain Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, CNS/Neurology
| Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Hair Care, Drug Discovery, Dermatology
| Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Functional (Non Ulcer) Dyspepsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery, Gastrointestinal
| Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Non-Alcoholic Steatohepatitis (NASH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Manufacturing, Packaging & Detailing, Drug Discovery
| Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Secondary Hyperparathyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Systemic Sclerosis (Scleroderma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| House Dust Mite Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Allergic Conditions, Drug Discovery, Allergy/Immunology
| Birch Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Allergic Conditions, Drug Discovery, Allergy/Immunology
| Typhoid Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
| Botulism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Topics: Drug Discovery
|
Prev | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|